AbbVie

Open: 138.36 Close: 138.3 Change: -0.06

16 risks of investing in AbbVie found by an AI after reading the whole internet.

This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Inc, company, market, value, drug, Signals, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

12 stock analysts on Stockchase covered Abbvie Inc. On 2023-11-17, the company will be worth watching. The current AbbVie [ ABBV ] share price is $138.30, making it a Sell signal.

Today's News

AbbVie Inc. shares have declined in 1-month, 3-month and 10-month periods. Pfizers $21 billion drug Humira is on the Decline. AbbVie Inc. (ABBV-N) reported positive data for migraine drug candidate. The company is favored on Wall Street ahead of Q3 earnings. AbbVie Inc. (ABBV-N) Rating: 4 out of 5 Bullish - Buy Buy Signals / Votes : 8 Neutral - Hold Signals - 0 Bearish - Sell Signals. 12 stock analysts on Stockchase covered Abbvie Inc. On 2023-11-17, the company will be worth watching. AbbVie Inc. (ABBV) recently announced Upadacitinib (RINVOQ) Met the Primary Endpoint in Phase 2 Clinical Trial of Vitiligo. AbbVie Inc. is a specialty biopharmaceutical company, which discovers, develops, manufactures, manufactures and commercializes drugs for the treatment of chronic diseases. The firm offers treatments for diseases including multiple sclerosis, parkinsons, and alzheimers disease. The current AbbVie [ ABBV ] share price is $138.30, making it a Sell signal. The Score for AbBV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal. No information on this site is provided with the intention to give medical advice. AbbVie stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences. The company is committed to operating with integrity, driving innovation, transforming lives. Macroaxis does not own or have any residual interests in AbbVie Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Abbvie advice using the current market data and latest reported fundamentals. The market value of AbbVie Inc is measured differently than its book value, which is the value of the companys balance sheet. The companys market value can be influenced by many factors that dont directly affect its underlying business as a pandemic or market pessimism. AbbVie is a research-based biopharmaceutical company that was spun off from Abbott Laboratories in January 2013. Abbvies price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

How much time have you spent trying to decide whether investing in AbbVie? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Inc, company, market, value, drug, Signals, and the most common words in the summary are: abbvie, job, stock, market, inc, price, news, . One of the sentences in the summary was: 12 stock analysts on Stockchase covered Abbvie Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #job #stock #market #inc #price #news.